Abstract:Metabolites have been recognized as biomarkers for diagnostic testing and monitoring of many diseases (1). However, in comparison to many clinical tests that target nucleic acids and proteins, detection and quantification of metabolites, including those applied in point-of-care (POC)2 settings, have been less developed, despite the proven success of glucometers widely used by diabetics. A major contributing factor is the lack of methods that, once developed, can be generalized and applied to many other metabolites. Without such generalizable methods, the costs of development become higher and the resulting tests less affordable for home users. Although nucleic acid hybridization and the antibody generation can be generalized for detection of nucleic acids and proteins, respectively, metabolites have been difficult to detect with a generalized method. Furthermore, although a colorimetric sensor is convenient and thus suitable for POC detection, it is vulnerable to interferences from colors in samples such as in blood. Fluorescent sensors, in contrast, have many advantages in sensitivity, accuracy, and time response, but the requirement of an excitation light source increases the size of the detector and costs of detection. Recently, Yu et al. have taken a major step toward addressing these issues (2), by developing a paper-based enzymatic assay method in which many metabolites can be quantified through oxidation by nicotinamide adenine dinucleotide phosphate (NADPH) (Fig. 1A), resulting in ratiometric changes in bioluminescence that can be quantified with a digital camera without a need for an excitation source. Fig. 1. Scheme of metabolite quantification by an engineered semisynthetic NADPH-dependent protein. A specific enzymatic reaction is performed in a reaction buffer to oxidize the analyte of interest by NADP+ (A). Design of a BRET sensor for NADPH (B). A protein chimera between a receptor and a luciferase (NanoLuc) is tethered via a SNAP-tag to a ligand derivatized with a fluorophore. NADPH triggers ligand binding to the receptor, thereby increasing …

BRET Nano Q-Body: A Nanobody-Based Ratiometric Bioluminescent Immunosensor for Point-of-Care Testing

Development of a nanobody tagged with streptavidin-binding peptide and its application in a Luminex fluoroimmunoassay for alpha fetal protein in serum

Double-Enzymes-Mediated Bioluminescent Sensor for Quantitative and Ultrasensitive Point-Of-Care Testing

Paper‐Based Antibody Detection Devices Using Bioluminescent BRET‐Switching Sensor Proteins

NanoB2 to monitor interactions of ligands with membrane proteins by combining nanobodies and NanoBRET

Turning Antibodies into Ratiometric Bioluminescent Sensors for Competition-Based Homogeneous Immunoassays

Engineered Amber-Emitting Nano Luciferase and Its Use for Immunobioluminescence Imaging In Vivo

Highly bright and stable NIR-BRET with blue-shifted coelenterazine derivatives for deep-tissue imaging of molecular events in vivo

Distance-Based Fluorescent Immunosensor for Point-of-Care Test of Illegal Additives through the Gas-Producing Nanozyme

Self-Assembly Multivalent Fluorescence-Nanobody Coupled Multifunctional Nanomaterial with Colorimetric Fluorescence and Photothermal to Enhance Immunochromatographic Assay

Mix-and-Read Nanobody-Based Sandwich Homogeneous Split-Luciferase Assay for the Rapid Detection of Human Soluble Epoxide Hydrolase

Advancing Point-of-Care Diagnostics of Metabolites Through Engineering Semisynthetic Proteins

Efficient Nanozyme-Triggered Pressure Sensor for Point-of-Care Immunoassay: Visual Sensing and Time Readout Device

Coupling optogenetic stimulation with NanoLuc-based luminescence (BRET) Ca++ sensing

One-Component Dual-Readout Aggregation-Induced Emission Nanobeads for Qualitative and Quantitative Detection of C-Reactive Protein at the Point of Care

Bioluminescence Resonance Energy Transfer (BRET)-Mediated Protein Release from Self-Illuminating Photoresponsive Biomaterials

Quantum dot/carrier-protein/haptens conjugate as a detection nanobioprobe for FRET-based immunoassay of small analytes with all-fiber microfluidic biosensing platform

Multiplex Detection of Fluorescent Chemokine Binding to CXC Chemokine Receptors by NanoBRET

Nanomechanical sensor for rapid and ultrasensitive detection of tumor markers in serum using nanobody

Nanozyme and bifunctional nanobody-based colorimetric-SERS dual-mode Immunosensor for microcystin-LR detection

Electrochemiluminescence immunoassay for the N-terminal pro-B-type natriuretic peptide based on resonance energy transfer between a self-enhanced luminophore composed of silver nanocubes on gold nanoparticles and a metal-organic framework of type MIL-125